| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Sunitinib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.1 |
| mRNA | MK-2206 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | AZD4547 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | HG-5-113-01 | GDSC1000 | pan-cancer | AAC | 0.074 | 0.1 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | BRD-K27188169:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | Bortezomib | gCSI | pan-cancer | AAC | 0.097 | 0.1 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.089 | 0.1 |
| mRNA | CP724714 | GDSC1000 | pan-cancer | AAC | -0.055 | 0.1 |